Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1

Emu, B; Fessel, J; Schrader, S; Kumar, P; Richmond, G; Win, S; Weinheimer, S; Marsolais, C; Lewis, S

Lewis, S (reprint author), TaiMed Biol, 2 Execut Circle,Suite 280, Irvine, CA 92614 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2018; 379 (7): 645

Abstract

BACKGROUND Ibalizumab, a humanized IgG4 monoclonal antibody, blocks the entry of human immunodeficiency virus type 1 (HIV-1) by noncompetitive binding......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索